High frequency of chronic end-stage liver disease and hepatocellular carcinoma in a Hispanic population

Journal of Gastroenterology and Hepatology (Australia)

Volumn 19, Issue 3, 2004, Pages 289-295

  Perez, Adriana ^a   Anzaldua, Monica ^a   Mccormick, Joseph ^a   Fisher Hoch, Susan ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Disparities; Hepatitis; Minority; Prevalence

Indexed keywords

ALCOHOL;

ADULT; ALCOHOL CONSUMPTION; ANAMNESIS; ARTICLE; CASE CONTROL STUDY; CHRONIC LIVER DISEASE; COMMUNITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ABUSE; FEMALE; HISPANIC; HOSPITAL DEPARTMENT; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTPATIENT DEPARTMENT; PATIENT REFERRAL; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; UNITED STATES;

EID: 1542512094     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2003.03277.x     Document Type: Article

References (25)

1. El-Serag H, Mason A. Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med. 1999; 340: 745-50.
2. Devesa SS, Grauman DG, Blot WJ, Pennello G, Hoover RN, Fraumeni Jr JF. Atlas of Cancer Mortality in the United States, 1950-94. NIH Publ. No. 99-4564. Washington, DC: US Government Printing Office, 1999.
3. Texas Department of Health. EPIGRAM Population and Mortality Data Analysis Software. Austin, TX: Texas Department of Health, 2003.
4. Office of Border Health and Texas A&M Policy Research Institute. Survey of Health and Environmental Conditions in Texas Border Counties and Colonias. Austin, Texas: Texas Department of Health, 2000.
5. Alter MJ. Hepatitis C virus infection in the United States. J. Hepatol. 1999; 31 (Suppl. 1): 88-91.
6. Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann. Intern. Med. 2000; 132: 296-305.
7. Ockner RK, Kaikaus RM, Bass NM. Fatty-acid metabolism and the pathogenesis of hepatocellular carcinoma: review and hypothesis. Hepatology 1993; 18: 669-76.
8. Kuper H, Ye W, Broome U et al. The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis. Hepatology 2001; 34: 714-18.
9. Kuper H, Tzonou A, Kaklamani E et al. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int. J. Cancer 2000; 85: 498-502.
10. Lagiou P, Kuper H, Stuver SO, Tzonou A, Trichopoulos D, Adami HO. Role of diabetes mellitus in the etiology of hepatocellular carcinoma. J. Natl Cancer Inst. 2000; 92: 1096-9.
11. Gelderblom WC, Marasas WF, Lebepe-Mazur S, Swanevelder S, Vessey CJ, Hall PL. Interaction of fumonisin B (1) and aflatoxin B (1) in a short-term carcinogenesis model in rat liver. Toxicology 2002; 171: 161-73.
12. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990; 11: 74-80.
13. Reddy JK. Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2001; 281: G1333-9.
14. Pessayre D, Mansouri A, Fromenty B. Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2002; 282: G193-9.
15. Sanyal AJ, Campbell-Sargent C, Mirshahi F et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120: 1183-92.
16. Center for Disease Control. Behavioral Risk Factor Surveillance System. Atlanta: Center for Disease Control and Prevention, 2000.
17. Texas Department of Health. The Texas Behavioral Risk Factor Surveillance System. Austin, TX: Texas Department of Health, 2002.
18. Allaben WT, Bucher JR, Howard PC. International conference on the toxicology of fumonisin: introduction. Environ. Health Perspect. 2001; 109 (Suppl. 2): 237.
19. Federal Reserve Bank of Dallas. The Border Economy. 2001. Available from: URL: http://www.dallasfed.org/research/border/tbe_issue.pdf
20. United States Department of Commerce, US Census Bureau. 2000 Population Estimates. Washington, DC: Bureau of the Census, 2002.
21. Instituto Nacional de Estadistica, Geografia e Informática. XII. Censo General de Poblacion y Vivienda 2000. Sistema Municipal de Base de Datos (SIMBAD). Poblacion Total Segun Localidades. Mexico City: Instituto Nacional de Estadistica, Geografia e Informatica, 2001.
22. Luby SP, Qamruddin K, Shah AA et al. The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiol. Infect. 1997; 119: 349-56.
23. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997; 26 (3 Suppl. 1): 62S-65S.
24. Angulo P. Nonalcoholic fatty liver disease. N. Engl. J. Med. 2002; 346: 1221-31.
25. Tsega E. Epidemiology, prevention and treatment of viral hepatitis with emphasis on new developments. Ethiop. Med. J. 2000; 38: 131-41.